Name:  ___.               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___ has class III morbid obesity with 
weight of 383.5 pounds as of ___ with his initial screen 
weight of 363.8 pounds on ___, height of 69 inches and BMI 
of 56.6.  His previous weight loss efforts have included Weight 
Watchers, the ___ diet, The Zone diet, ___ 
___, over-the-counter dietary supplement Metabolife, RD visits 
and self-directed diets with exercise losing up to 95 pounds and 
had lost 85 pounds on the ___ diet, but he has been unable to 
maintain whatever weight he had loss for any significant length 
of time.  He has not taken prescription weight loss medications. 
 He stated that his lowest adult weight was 210 pounds at the 
age of ___ and his highest weight was 392.5 pounds on ___.  
He stated that he has been struggling with weight since high 
school and cites as factors contributing to his excess weight 
large portions, too many carbohydrates and saturated fats, 
late-night eating, emotional and compulsive eating, stress, 
convenience eating and lack of exercise.  He does like to bowl 
and is involved with a bowling league for ___ hours twice a week 
and he walks to/from the train station about 1.5 hours per day.  
He denied history of eating disorders and he stated that he does 
binge eat without purging several times a week but has not done 
so in over 8 months.  He does have depression/anxiety and he is 
followed by a therapist once a month for weight related issues, 
has not been hospitalized for mental health issues and he is on 
psychotropic medication (bupropion).

 
Past Medical History:
1)  severe obstructive sleep apnea with significant hypoxia on 
    CPAP followed in Sleep Clinic
2)  asthma on inhaler with no recent flare or prednisone taper
3)  ulcerative colitis
4)  heartburn/reflux
5)  colonic polyps
6)  history of chest pain with no cardiac etiology
7)  hyperlipidemia
8)  vitamin D deficiency
9)  mild and deficiency with saturation of 18%

He has no surgical history.

 
Social History:
___
Family History:
His family history is noted for both parents living father with 
thyroid disorder and sleep apnea; mother with kidney disease, 
arthritis, hyperlipidemia, sleep apnea and obesity; sister 
living with obesity.

 
Physical Exam:
T 99.2 BP 102/58 P 78 RR ___ Ra 
General: no acute distress
Cardiac: regular rate and rhythm
Resp: clear to auscultation, bilaterally
Abdomen: soft, appropriately tender to palpation, bilaterally; 
no rebound tenderness or guarding
Wounds: abd lap sites with staples, CDI
Ext: no lower extremity edema or tenderness, bilaterally
 
Pertinent Results:
___ 04:14AM BLOOD Hct-40.8
___ 03:00PM BLOOD Hct-43.5
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia and surgery and then taken to the 
operating room for a laparoscopic sleeve gastrectomy for 
obesity. There were no adverse events in the operating room; 
please see the operative note for details. Pt was extubated, 
taken to the PACU until stable, then transferred to the ward for 
observation.  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
liquid oral pain medication once tolerating a stage 3 diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. BuPROPion XL (Once Daily) 150 mg PO DAILY 
2. Fluticasone Propionate NASAL 1 SPRY NU ASDIR 
3. Multivitamins 1 TAB PO DAILY 
4. albuterol sulfate 90 mcg/actuation inhalation ASDIR 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 650 mg/20.3 mL 20 mL po Q 6 hrs Disp #*300 
Milliliter Refills:*0 
2.  BuPROPion 100 mg PO BID  
3.  docusate sodium 50 mg/5 mL oral BID:PRN 
RX *docusate sodium 50 mg/5 mL 100 mg by mouth twice a day 
Refills:*0 
4.  Famotidine 20 mg PO BID 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
5.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every four (4) hours 
Refills:*0 
6.  albuterol sulfate 90 mcg/actuation inhalation ASDIR  
7.  Fluticasone Propionate NASAL 1 SPRY NU ASDIR  
8.  Multivitamins 1 TAB PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity
Obstructive sleep apnea

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Please call your surgeon or return to the Emergency Department 
if you develop a fever greater than ___ F, shaking chills, chest 
pain, difficulty breathing, pain with breathing, cough, a rapid 
heartbeat, dizziness, severe abdominal pain, pain unrelieved by 
your pain medication, a change in the nature or severity of your 
pain, severe nausea, vomiting, abdominal bloating, severe 
diarrhea, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness, swelling from your 
incisions, or any other symptoms which are concerning to you.
Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 3000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___